GLP-1 is a natural human hormone that regulates blood glucose levels. Scientists have now created long-lasting GLP-1 drugs ...

Discover a study comparing tirzepatide, semaglutide, and liraglutide in MASLD, revealing significant reductions in liver ...

An estimated 25% of Medicaid enrollees had restricted availability of SGLT2 inhibitors and 40% had restricted availability of GLP-1 agents. Availability of GLP-1 receptor agonists with managed care ...

iControlled for family-wise type 1 error rate. iiPercentage of participants achieving body weight reductions of ≥20% with orforglipron 6 mg was not controlled for ...

Ozempic, marketed by Novo Nordisk in India, is primarily indicated for the treatment of type 2 diabetes. While it can lead to moderate weight loss as a secondary effect due to its action as a GLP-1 ...

People with obesity and type 2 diabetes who undergo metabolic surgery live longer and face fewer serious health problems.

A new class of weight-loss drug has shown it can significantly boost weight loss when paired with GLP-1 therapy – without ...

Metabolic surgery was associated with lower all-cause mortality and a lower risk for major adverse cardiac events than GLP-1 receptor agonists (RAs), based on data from a new study of more than 3000 ...

In the prevention of kidney disease in patients with type 2 diabetes (T2D) and mildly reduced kidney function, SGLT2 inhibitors (SGLT2i) showed a stronger benefit than GLP-1 receptor agonists (RA) and ...

Do natural GLP-1 alternatives work? This article was reviewed by Brian Tanzer, nutritionist and Director of Scientific and Regulatory Affairs at The Vitamin Shoppe. As the saying goes, food is ...